European public procurement and grants data from official registers · Data as of 21 November 2026; updated daily.

Market report

Dermatological drug tenders in Czechia — market report, September 2025

Dermatological drug tenders in Czechia in September 2025: 7,228 tenders published (+21% month on month, +27% year on year), estimated at €292,962 in total, and 7,251 contracts awarded (+21% month on month, +28% year on year), worth €12,678,450 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,382), Krajská zdravotní, a.s. (826) and Fakultní nemocnice Brno (499); most contracts won: ROCHE s.r.o. (175), ViaPharma s.r.o. (167) and Janssen-Cilag s.r.o. (118). On average 1.7 bids per contract; 60% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
7,228
Contracts awarded
7,251
Contract value awarded
€12,678,450
Bids per contract
1.7
Tenders published per month
05K10KSep 24: 5,695Sep 24: 5,695Sep 24Oct 24: 7,005Oct 24: 7,005Oct 24Nov 24: 6,299Nov 24: 6,299Nov 24Dec 24: 6,565Dec 24: 6,565Dec 24Jan 25: 4,714Jan 25: 4,714Jan 25Feb 25: 9,302Feb 25: 9,302Feb 25Mar 25: 8,827Mar 25: 8,827Mar 25Apr 25: 8,045Apr 25: 8,045Apr 25May 25: 6,887May 25: 6,887May 25Jun 25: 7,049Jun 25: 7,049Jun 25Jul 25: 6,801Jul 25: 6,801Jul 25Aug 25: 5,988Aug 25: 5,988Aug 25Sep 25: 7,228Sep 25: 7,2287,228Sep 25
Contracts awarded per month
05K10KSep 24: 5,682Sep 24: 5,682Sep 24Oct 24: 7,008Oct 24: 7,008Oct 24Nov 24: 6,301Nov 24: 6,301Nov 24Dec 24: 6,569Dec 24: 6,569Dec 24Jan 25: 4,725Jan 25: 4,725Jan 25Feb 25: 9,292Feb 25: 9,292Feb 25Mar 25: 8,846Mar 25: 8,846Mar 25Apr 25: 8,051Apr 25: 8,051Apr 25May 25: 6,901May 25: 6,901May 25Jun 25: 7,070Jun 25: 7,070Jun 25Jul 25: 6,810Jul 25: 6,810Jul 25Aug 25: 6,004Aug 25: 6,004Aug 25Sep 25: 7,251Sep 25: 7,2517,251Sep 25

The highlighted bar is September 2025. Hover a bar for its figure; the table below has every value.

FigureSeptember 2025August 2025ChangeSeptember 2024Change
Tenders published7,2285,988+21%5,695+27%
Estimated value€292,962€97,682+200%€2,002,721-85%
Buyers3130+3%310%
Contracts awarded7,2516,004+21%5,682+28%
Contract value (awarded)€12,678,450€4,347,195+192%——
Winners290264+10%252+15%
Bids per contract1.71.8———
Single-bid contracts60%40%———

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Ústecký kraj 1
  • Olomoucký kraj 1
  • Moravskoslezský kraj 1

Procedures

  • not stated 7,225
  • Open procedure 2
  • Other procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Czechia in September 2025?
7,228 (by 31 buyers); for comparison, August 2025: 5,988, September 2024: 5,695.
Who won the most dermatological drug tenders in Czechia in September 2025?
By number of contracts: ROCHE s.r.o. (175), ViaPharma s.r.o. (167), Janssen-Cilag s.r.o. (118), AbbVie s.r.o. (100) and Amgen s.r.o. (91); 290 companies won contracts in all.
Which buyers published the most dermatological drug tenders in September 2025?
Krajská nemocnice T. Bati, a. s. (2,382), Krajská zdravotní, a.s. (826), Fakultní nemocnice Brno (499), Fakultní nemocnice Bulovka (467) and Nemocnice České Budějovice, a.s. (340).
How competitive were dermatological drug tenders in Czechia in September 2025?
On average 1.7 bids per contract (20 contracts with a known number of bids); 60% of contracts had a single bid.
What were the contracts worth in September 2025?
€12,678,450 (awarded value, 7,251 contracts); median about €770,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.